We are live on ! Find out more
BC

Blackcrane Capital Portfolio holdings

AUM $16.3M
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+15.74%
1 Year Est. Return
-19.53%
3 Year Est. Return
+40.04%
5 Year Est. Return
10 Year Est. Return
AUM
$125M
AUM Growth
+$50.1M
Cap. Flow
+$48.8M
Cap. Flow %
38.93%
Top 10 Hldgs %
100%
Holding
14
New
5
Increased
1
Reduced
1
Closed
4

Top Buys

Rank Stock Value
1
RCEL icon
Avita Medical
RCEL
+$45.6M
2
WIX icon
WIX.com
WIX
+$13M
3
AXNX
Axonics, Inc. Common Stock
AXNX
+$10.8M
4
TSCO icon
Tractor Supply
TSCO
+$8.37M
5
CC icon
Chemours
CC
+$4.17M

Top Sells

Rank Stock Value
1
FTI icon
TechnipFMC
FTI
+$10.6M
2
COLD icon
Americold
COLD
+$10M
3
IQV icon
IQVIA
IQV
+$5.55M
4
WMGI
Wright Medical Group Inc
WMGI
+$5.43M
5
MSFT icon
Microsoft
MSFT
+$1.53M

Sector Composition

Rank Sector Weight
1 Healthcare 64.19%
2 Technology 21.65%
3 Consumer Discretionary 6.58%
4 Financials 3.96%
5 Materials 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCEL icon
1
Avita Medical
RCEL
$157M
$49.9M 39.86%
+1,097,504
New +$45.6M
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$14.6M 11.64%
267,900
+172
+0.1% +$8.52K
WIX icon
3
WIX.com
WIX
$2.15B
$12.9M 10.34%
+105,816
New +$13M
NICE icon
4
Nice
NICE
$5.87B
$12.9M 10.26%
82,869
AXNX
5
DELISTED
Axonics, Inc. Common Stock
AXNX
$12.5M 9.97%
+451,000
New +$10.8M
TSCO icon
6
Tractor Supply
TSCO
$16B
$8.24M 6.58%
+441,040
New +$8.37M
V icon
7
Visa
V
$682B
$4.96M 3.96%
26,391
CC icon
8
Chemours
CC
$2.63B
$4.55M 3.63%
+251,316
New +$4.17M
TAK icon
9
Takeda Pharmaceutical
TAK
$54.8B
$3.41M 2.72%
172,708
MSFT icon
10
Microsoft
MSFT
$2.93T
$1.31M 1.05%
83,302
-10,437
-11% -$1.53M
COLD icon
11
Americold
COLD
$4.54B
-269,954
Closed -$10M
FTI icon
12
TechnipFMC
FTI
$28.7B
-591,879
Closed -$10.6M
IQV icon
13
IQVIA
IQV
$34.4B
-37,188
Closed -$5.55M
WMGI
14
DELISTED
Wright Medical Group Inc
WMGI
-263,214
Closed -$5.43M

Similar funds

Blackcrane Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Blackcrane Capital held 14 positions worth $125M, up 67% from $75.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Blackcrane Capital deployed $48.8M of net new capital in Q4 2019, opening 5 new positions and adding to 1 existing holding. Its largest new stake was Avita Medical: 1,097,504 shares worth $49.9M.

By sector, the portfolio is most concentrated in Healthcare at 64% of assets, up from 33% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Microsoft, an estimated $1.53M trimmed.

  • Blackcrane Capital's largest Q4 2019 buy was Avita Medical: 1,097,504 shares worth $49.9M.
  • Blackcrane Capital added most to Biohaven Pharmaceutical Holding Company Ltd. in Q4 2019, an estimated $8.52K increase.
  • Blackcrane Capital's biggest Q4 2019 reduction was Microsoft, cutting an estimated $1.53M.
  • Blackcrane Capital fully exited TechnipFMC in Q4 2019, selling an estimated $10.6M.
  • Blackcrane Capital's ten largest holdings make up 100% of its $125M portfolio in Q4 2019.
  • Blackcrane Capital opened 5 new positions and closed 4 in Q4 2019.
  • Blackcrane Capital's portfolio value rose 67% quarter-over-quarter to $125M.

Based on Blackcrane Capital's 13F filing for Q4 2019, filed 12 Feb 2020.